Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2.

Princiotta Cariddi, L., Tabaee Damavandi, P., Carimati, F., Banfi, P., Clemenzi, A., Marelli, M., et al. (2020). Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. JOURNAL OF NEUROLOGY, 267(11), 3157-3160 [10.1007/s00415-020-10001-7].

Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient

Tabaee Damavandi, P.
Co-primo
;
2020

Abstract

Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2.
Lettera in rivista
COVID-19; Endothelial dysfunction; Reversible encephalopathy syndrome PRES;
English
2020
267
11
3157
3160
reserved
Princiotta Cariddi, L., Tabaee Damavandi, P., Carimati, F., Banfi, P., Clemenzi, A., Marelli, M., et al. (2020). Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. JOURNAL OF NEUROLOGY, 267(11), 3157-3160 [10.1007/s00415-020-10001-7].
File in questo prodotto:
File Dimensione Formato  
Princiotta Cariddi-2020-J Neurol-VoR.pdf

Solo gestori archivio

Descrizione: Letter to the Editor
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 648.47 kB
Formato Adobe PDF
648.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/405382
Citazioni
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 65
Social impact